(Q38208263)

31 August 2017

title

IRF4 at the crossroads of effector T-cell fate decision (English)

1 reference

31 August 2017

Magdalena Huber

1

1 reference

31 August 2017

Michael Lohoff

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

16 June 2014

1 reference

European Journal of Immunology

31 August 2017

published in

1 reference

31 August 2017

volume

44

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

1886-1895

1 reference

IRF4: Immunity. Malignancy! Therapy?

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The diverse roles of IRF4 in late germinal center B-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Roles of interferon-regulatory factors in T-helper-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The IRF family transcription factors in immunity and oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Crystal structure of PU.1/IRF-4/DNA ternary complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

BATF-JUN is critical for IRF4-mediated transcription in T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Compensatory dendritic cell development mediated by BATF-IRF interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

A validated regulatory network for Th17 cell specification

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

STAT6-dependent regulation of Th9 development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

PU.1 expression delineates heterogeneity in primary Th2 cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Differentiation of effector CD4 T cell populations (*)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcriptional regulation of follicular T-helper (Tfh) cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Regulatory T cells: mechanisms of differentiation and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.201344279

1 reference

7 January 2021

Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Modulation of T cell cytokine production by interferon regulatory factor-4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Th9 cell development requires a BATF-regulated transcriptional network

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Batf coordinates multiple aspects of B and T cell function required for normal antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The AP-1 transcription factor Batf controls T(H)17 differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Differentiation and function of Foxp3(+) effector regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Regulating functional cell fates in CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcriptional control of effector and memory CD8+ T cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Transcriptional regulation of effector and memory CD8+ T cell fates.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Type 17 CD8+ T cells display enhanced antitumor immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Metabolic checkpoints in activated T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Tc17 CD8 T cells: functional plasticity and subset diversity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Metabolic regulation of T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344279

7 January 2021

Identifiers

DOI

10.1002/EJI.201344279

1 reference

31 August 2017

1 reference